• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[源自RD细胞的RD-9H8细胞对肠道病毒的敏感性及其在检测抗B组柯萨奇病毒中和抗体中的应用]

[Susceptibility of RD-9H8 cells derived from RD cells to enteroviruses and its application for measuring neutralizing antibodies against coxsackievirus group B].

作者信息

Yanagihara T, Matsumoto I, Kawana R

机构信息

Department of Bacteriology, School of Medicine, Iwate Medical University.

出版信息

Kansenshogaku Zasshi. 1992 Apr;66(4):484-9. doi: 10.11150/kansenshogakuzasshi1970.66.484.

DOI:10.11150/kansenshogakuzasshi1970.66.484
PMID:1320655
Abstract

We carried out cloning of RD cells and obtained cloned cell line RD-9H8, which is highly sensitive to enteroviruses. Cytopathic effect (CPE) of RD-9H8 cells was more remarkable than that of original RD cells. The RD-9H8 cells were used to measure the neutralizing antibodies to coxsackievirus group B in sera from 93 medical students collected in Oct. 1990 at Iwate Medical University. The proportions of confirmed positive sera were coxsackievirus type B1 44.1%, type B2 50.5%, type B3 46.2%, type B4 64.5%, type B5 53.8% and type B6 4.4%.

摘要

我们对RD细胞进行了克隆,获得了对肠道病毒高度敏感的克隆细胞系RD - 9H8。RD - 9H8细胞的细胞病变效应(CPE)比原始RD细胞更显著。利用RD - 9H8细胞检测了1990年10月在岩手医科大学收集的93名医学生血清中针对B组柯萨奇病毒的中和抗体。确诊阳性血清的比例分别为:B1型柯萨奇病毒44.1%、B2型50.5%、B3型46.2%、B4型64.5%、B5型53.8%和B6型4.4%。

相似文献

1
[Susceptibility of RD-9H8 cells derived from RD cells to enteroviruses and its application for measuring neutralizing antibodies against coxsackievirus group B].[源自RD细胞的RD-9H8细胞对肠道病毒的敏感性及其在检测抗B组柯萨奇病毒中和抗体中的应用]
Kansenshogaku Zasshi. 1992 Apr;66(4):484-9. doi: 10.11150/kansenshogakuzasshi1970.66.484.
2
[Neutralizing antibodies to Coxsackie virus group B 1986-1988].
Vojnosanit Pregl. 1990 Jul-Aug;47(4):294-6.
3
Serologic prevalence of coxsackievirus group B in Greece.希腊B组柯萨奇病毒的血清学流行率。
Viral Immunol. 2007 Spring;20(1):11-8. doi: 10.1089/vim.2006.0085.
4
Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM.用于检测柯萨奇病毒B4和B5特异性IgM的抗体捕获放射免疫分析(MACRIA)
J Hyg (Lond). 1983 Jun;90(3):333-49. doi: 10.1017/s0022172400028977.
5
A comparison of the susceptibility of three human gut tumour-derived differentiated epithelial cell lines, primary monkey kidney cells and human rhabdomyosarcoma cell line to 66-prototype strains of human enteroviruses.三种源自人肠道肿瘤的分化上皮细胞系、原代猴肾细胞和人横纹肌肉瘤细胞系对66种人肠道病毒原型株的敏感性比较。
J Virol Methods. 1985 Dec;12(3-4):209-16. doi: 10.1016/0166-0934(85)90131-4.
6
Human rhabdomyosarcoma cells for rapid detection of enteroviruses by shell-vial assay.用于通过空斑试验快速检测肠道病毒的人横纹肌肉瘤细胞。
J Med Microbiol. 2003 Sep;52(Pt 9):789-791. doi: 10.1099/jmm.0.05237-0.
7
Maternal and neonatal neutralizing antibody titers to selected enteroviruses.母体和新生儿针对特定肠道病毒的中和抗体滴度。
Pediatr Infect Dis. 1985 Jan-Feb;4(1):32-5. doi: 10.1097/00006454-198501000-00009.
8
Neutralizing antibodies to non-polio enteroviruses in human immune serum globulin.
Pediatr Infect Dis. 1983 Nov-Dec;2(6):454-6. doi: 10.1097/00006454-198311000-00009.
9
Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells.柯萨奇病毒B2在缺乏柯萨奇病毒和腺病毒受体的横纹肌肉瘤细胞中的溶细胞性复制
Virus Res. 2005 Nov;113(2):107-15. doi: 10.1016/j.virusres.2005.04.021.
10
Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade.通过受体阻断抑制特定肠道病毒感染HeLa细胞和横纹肌肉瘤细胞的单克隆抗体。
J Virol. 1986 Feb;57(2):438-45. doi: 10.1128/JVI.57.2.438-445.1986.